These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 6090888)

  • 21. Antiviral activity of cyclosaligenyl prodrugs of the nucleoside analogue bromovinyldeoxyuridine against herpes viruses.
    Meerbach A; Meier C; Sauerbrei A; Meckel HM; Wutzler P
    Int J Antimicrob Agents; 2006 May; 27(5):423-30. PubMed ID: 16621459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-activity relationship of the affinity of 5-substituted uracil nucleoside analogues for varicella-zoster virus thymidine kinase and their activity against varicella-zoster virus.
    Ashida N; Watanabe Y; Miura S; Kano F; Sakata S; Yamaguchi T; Suzutani T; Machida H
    Antiviral Res; 1997 Aug; 35(3):167-75. PubMed ID: 9298756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deoxythymidine kinases in varicella-zoster virus infected and biochemically transformed cells.
    Ogino T; Lopetegui P; Yamanishi K
    Biken J; 1982 Sep; 25(3):149-56. PubMed ID: 6299267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
    De Clercq E; Descamps J; Ogata M; Shigeta S
    Antimicrob Agents Chemother; 1982 Jan; 21(1):33-8. PubMed ID: 6282207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs.
    Andrei G; Topalis D; Fiten P; McGuigan C; Balzarini J; Opdenakker G; Snoeck R
    J Virol; 2012 Mar; 86(5):2641-52. PubMed ID: 22190713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the mechanism of selective inhibition of herpesvirus replication by (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Allaudeen HS; Kozarich JW; Bertino JR; De Clercq E
    Proc Natl Acad Sci U S A; 1981 May; 78(5):2698-702. PubMed ID: 6265902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
    Balzarini J; Bohman C; Walker RT; de Clercq E
    Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine.
    Russ P; Schelling P; Scapozza L; Folkers G; Clercq ED; Marquez VE
    J Med Chem; 2003 Nov; 46(23):5045-54. PubMed ID: 14584954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphism of thymidine kinase (TK) and DNA polymerase (pol) of clinical varicella-zoster virus (VZV) isolates collected over three decades.
    Hoffmann A; Döring K; Seeger NT; Bühler M; Schacke M; Krumbholz A; Sauerbrei A
    J Clin Virol; 2017 Oct; 95():61-65. PubMed ID: 28886462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents.
    Snoeck R; Schols D; Sadzot-Delvaux C; Cloes JM; Andrei G; De Clercq E; Piette J; Rentier B
    J Virol Methods; 1992 Aug; 38(2):243-54. PubMed ID: 1325472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells.
    Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA
    Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-Iodo-2'-deoxy-L-uridine and (E)-5-(2-bromovinyl)-2'-deoxy-L-uridine: selective phosphorylation by herpes simplex virus type 1 thymidine kinase, antiherpetic activity, and cytotoxicity studies.
    Spadari S; Ciarrocchi G; Focher F; Verri A; Maga G; Arcamone F; Iafrate E; Manzini S; Garbesi A; Tondelli L
    Mol Pharmacol; 1995 Jun; 47(6):1231-8. PubMed ID: 7603465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of thymidine kinase and DNase in varicella-zoster virus-infected cells and kinetic properties of the virus-induced thymidine kinase.
    Cheng YC; Tsou TY; Hackstadt T; Mallavia LP
    J Virol; 1979 Jul; 31(1):172-7. PubMed ID: 228052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 6-azapyrimidine-2'-deoxy-4'-thionucleosides: antiviral agents against TK+ and TK- HSV and VZV strains.
    Maslen HL; Hughes D; Hursthouse M; De Clercq E; Balzarini J; Simons C
    J Med Chem; 2004 Oct; 47(22):5482-91. PubMed ID: 15481985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis induced by (E)-5-(2-bromovinyl)-2'-deoxyuridine in varicella zoster virus thymidine kinase-expressing cells is driven by activation of c-Jun/activator protein-1 and Fas ligand/caspase-8.
    Tomicic MT; Friedrichs C; Christmann M; Wutzler P; Thust R; Kaina B
    Mol Pharmacol; 2003 Feb; 63(2):439-49. PubMed ID: 12527816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.
    Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE
    J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
    Suzuki M; Okuda T; Shiraki K
    Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Schnute ME; Cudahy MM; Brideau RJ; Homa FL; Hopkins TA; Knechtel ML; Oien NL; Pitts TW; Poorman RA; Wathen MW; Wieber JL
    J Med Chem; 2005 Sep; 48(18):5794-804. PubMed ID: 16134946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic studies of the predicted substrate-binding site of varicella-zoster virus thymidine kinase.
    Suzutani T; Davies LC; Honess RW
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1011-6. PubMed ID: 8389797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
    Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.